Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Maj 2016

Planlagt Fastgjort Låst Flyttet Genmab
2.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • FantomasF Offline
    FantomasF Offline
    Fantomas
    wrote on sidst redigeret af
    #1104

    Dara kommer til at sende hematology læger på pension..

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #1105

      Heftige data - nogen der har Elotuzumab data ved hånden ?

      1 Reply Last reply
      0
      • G Offline
        G Offline
        gentogen
        wrote on sidst redigeret af
        #1106

        OFC is a rapidly acting combination, inducing high response rates, including deep and durable responses in heavily pretreated WM patients, even in those refractory to rituximab and/or bortezomib. Ofatumumab is well tolerated

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #1107

          Elo: The co-primary endpoints of this study, progression-free survival (PFS) as assessed by hazard ratio (HR) and overall response rate (ORR), were achieved, with extended follow-up data showing a 53% relative improvement in PFS rate at three years (23% versus 15%). Additionally, a pre-specified interim analysis for overall survival (OS) found a positive trend favoring the Empliciti combination versus Rd alone (HR=0.77 [95% CI: 0.61, 0.97, p=0.0257])

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #1108

            Among the patients treated with Empliciti, Revlimid, and dex­a­meth­a­sone, 79 percent achieved at least a partial response to treatment, compared to 66 percent of the patients who received Revlimid and dex­a­meth­a­sone alone

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #1109

              Mere elo: he ERd regimen demonstrated a significant improvement in ORR of 78.5% (95% CI: 73.6-82.9; p=0.0002) versus 65.5% in the Rd arm (95% CI: 60.1-70.7).

              1 Reply Last reply
              0
              • investor1989I Offline
                investor1989I Offline
                investor1989
                wrote on sidst redigeret af
                #1110

                with 19% of pts with ≥3 prior lines of therapy

                1 Reply Last reply
                0
                • investor1989I Offline
                  investor1989I Offline
                  investor1989
                  wrote on sidst redigeret af
                  #1111

                  så der var også nogle syge patienter med i studiet

                  1 Reply Last reply
                  0
                  • investor1989I Offline
                    investor1989I Offline
                    investor1989
                    wrote on sidst redigeret af
                    #1112

                    Elo 78 % ORR. Dara 93 % og så en sindssyg 43 % CR oveni. Elo kan godt gå hjem nu

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #1113

                      Altså Elo+Rd 78,5% ORR. Dara+R+d 93%
                      ORR

                      1 Reply Last reply
                      0
                      • investor1989I Offline
                        investor1989I Offline
                        investor1989
                        wrote on sidst redigeret af
                        #1114

                        VGPR var hele 76 % !!! med Dara mod kun 44% i kontrolarmen

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #1115

                          Just a moment...

                          favicon

                          (www.nejm.org)

                          1 Reply Last reply
                          0
                          • M Offline
                            M Offline
                            MUFC_Oberanven
                            wrote on sidst redigeret af
                            #1116

                            Kursen er nu 1094

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #1117

                              Ja, nyheden er nået frem til markedet

                              1 Reply Last reply
                              0
                              • investor1989I Offline
                                investor1989I Offline
                                investor1989
                                wrote on sidst redigeret af
                                #1118

                                Prøv lige at tjekke PFS grafen for Dara. 80 % af patienter er stadig med efter 12 måneder !! Efter 21 måneder er de stadig omkring 75. Der går lang tid endnu før de rammer 50 og dermed finder median PFS..

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #1119

                                  man skal nok passe på at sammenligne alt for meget, men Dara ser godt nok stærk ud 🙂

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Sukkeralf
                                    wrote on sidst redigeret af
                                    #1120

                                    Ja Daras styrke er jo de lange dybe responser 🙂

                                    1 Reply Last reply
                                    0
                                    • investor1989I Offline
                                      investor1989I Offline
                                      investor1989
                                      wrote on sidst redigeret af
                                      #1121

                                      Det er nok også det der taler for at de 78 % VGPR gør at der med tiden bliver højere end 43 % CR. Når patienterne kan leve så længe med et VGPR er de nok i praksis reelt et CR når der bliver lavet bone marrow biopsi

                                      1 Reply Last reply
                                      0
                                      • H Offline
                                        H Offline
                                        Hlf
                                        wrote on sidst redigeret af
                                        #1122

                                        Runder vi de 1100,- idag ? 🙂

                                        1 Reply Last reply
                                        0
                                        • H Offline
                                          H Offline
                                          Hlf
                                          wrote on sidst redigeret af
                                          #1123

                                          Ja det skete så lige 😉

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger